Govt Job for B.Pharm, B.Sc in Department of Telemedicine PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Applications (with CV) are hereby invited for the different posts in Department of Telemedicine under “Science Technology & Innovation Hub in Leh, Leh Ladakh district, Ladakh (U.T)”.

Project Assistant – One
Qualification/ Eligibility : Graduation in Engineering / Medicine / Pharma or Graduation in Science with one year experience.

Salary : Rs. 22000/- (Consolidated)

Research Associate-I – One
Qualification/ Eligibility : MBBS degree from Indian University Institute recognised by the Medical Council of India or MCI recognised qualification equivalent there to for teaching post. The Candidate must be registered with State Medical Council/MCI.

Salary : Rs.47,600+16%HRA = 55,216/-

Interested candidates can submit their CV by 29.06.2021 till 4 PM, at Department of Telemedicine, Room No 20, 2nd Level, Nehru Hospital or by email (rrcpgimer@gmail.com).

Short listed candidates will be called for the interview on 01.07.2021 at 10 AM. Give your corrected email ID, as all further correspondence will be through email.

At the time of interview, candidates should bring their original certificates for verification. No separate interview letter will be sent and No TA/DA will be paid.

* Those candidate who have already applied for the post of project assistant need not to apply again.

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March